Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gruber

Showing results (191-200 of 355) with videos related to

Pageof 36
Sort By:
Journal of General Internal Medicine|July 18, 2008
Changes in medical students' attitudes towards end-of-life decisions across different years of medical trainingPascale C Gruber, Charles D Gomersall, Gavin M Joynt, et al.
The Pediatric Infectious Disease Journal|October 11, 2011
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Sylvia H Yeh, et al.
Vaccine|July 28, 2021
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of ageNicola P Klein, Paula Peyrani, Kari Yacisin, et al.
Vaccine|February 13, 2018
Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adultsJosé A Suaya, Qin Jiang, Daniel A Scott, et al.
Pediatrics|December 5, 2006
Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day careTimo Vesikari, Douglas M Fleming, Javier F Aristegui, et al.
Human Vaccines & Immunotherapeutics|August 8, 2018
Safety, tolerability, and immunogenicity of a novel 4-antigen <i>Staphylococcus aureus</i> vaccine (SA4Ag) in healthy Japanese adultsMegumi Inoue, Takuma Yonemura, James Baber, et al.
The Pediatric Infectious Disease Journal|April 16, 2013
Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United StatesTerry Payton, Douglas Girgenti, Robert W Frenck, et al.
Biochimica Et Biophysica Acta|May 8, 2012
The structure of monoacylglycerol lipase from Bacillus sp. H257 reveals unexpected conservation of the cap architecture between bacterial and human enzymesSrinivasan Rengachari, Gustavo A Bezerra, Lina Riegler-Berket, et al.
Chemical Communications (Cambridge, England)|May 31, 2006
Biocatalytic deuterium- and hydrogen-transfer using over-expressed ADH-'A': enhanced stereoselectivity and 2H-labeled chiral alcoholsKlaus Edegger, Christian C Gruber, Tina M Poessl, et al.
The Pediatric Infectious Disease Journal|April 28, 2009
Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive childrenHumberto Bracco Neto, Calil K Farhat, Miguel Wenceslao Tregnaghi, et al.
Pageof 36

Showing results (191-200 of 355) with videos related to

Sort By:
Pageof 36
Journal of General Internal Medicine|July 18, 2008
Changes in medical students' attitudes towards end-of-life decisions across different years of medical trainingPascale C Gruber, Charles D Gomersall, Gavin M Joynt, et al.
The Pediatric Infectious Disease Journal|October 11, 2011
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccineRobert Frenck, Allison Thompson, Sylvia H Yeh, et al.
Vaccine|July 28, 2021
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of ageNicola P Klein, Paula Peyrani, Kari Yacisin, et al.
Vaccine|February 13, 2018
Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adultsJosé A Suaya, Qin Jiang, Daniel A Scott, et al.
Pediatrics|December 5, 2006
Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day careTimo Vesikari, Douglas M Fleming, Javier F Aristegui, et al.
Human Vaccines & Immunotherapeutics|August 8, 2018
Safety, tolerability, and immunogenicity of a novel 4-antigen <i>Staphylococcus aureus</i> vaccine (SA4Ag) in healthy Japanese adultsMegumi Inoue, Takuma Yonemura, James Baber, et al.
The Pediatric Infectious Disease Journal|April 16, 2013
Immunogenicity, safety and tolerability of 3 lots of 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in the United StatesTerry Payton, Douglas Girgenti, Robert W Frenck, et al.
Biochimica Et Biophysica Acta|May 8, 2012
The structure of monoacylglycerol lipase from Bacillus sp. H257 reveals unexpected conservation of the cap architecture between bacterial and human enzymesSrinivasan Rengachari, Gustavo A Bezerra, Lina Riegler-Berket, et al.
Chemical Communications (Cambridge, England)|May 31, 2006
Biocatalytic deuterium- and hydrogen-transfer using over-expressed ADH-'A': enhanced stereoselectivity and 2H-labeled chiral alcoholsKlaus Edegger, Christian C Gruber, Tina M Poessl, et al.
The Pediatric Infectious Disease Journal|April 28, 2009
Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive childrenHumberto Bracco Neto, Calil K Farhat, Miguel Wenceslao Tregnaghi, et al.
Pageof 36